Scan Monthly No. 005July 2003 |
|
<< Other Issues of Scan Monthly |
Download this Scan™ Monthly (PDF) |
Speech-Mining and Translation Technologies: Looking for Traction in the Marketplace |
View summary |
D03-2434 | Download this Insight |
Two new speech-technology areas—speech mining and speech-to-speech translation—have great market potential, with promise to affect virtually every industry. Both areas are just beginning to move from the laboratory to early commercial applications. These advances are likely to provide tremendous benefits for many existing applications as well as to open completely new applications. Nonetheless, mass-market penetration of speech mining and speech-to-speech translation is unlikely anytime soon. Both technologies just entered the market and still display major shortcomings, including uneven reliability. Currently, the technologies can serve only well-defined application areas. But the stage is set for these new technology areas to enhance business processes, facilitate communications, and unlock a wide variety of consumer benefits. Though ongoing research and development are necessary to address critical problems, combining the technologies will provide even more powerful applications by freeing speech mining from language constraints. Author: Martin Schwirn. 15 pages. Index Keywords: Communication; Computer Software; Information Technology; Mobile Communications; Telecommunications. |
|
Nanobiotechnology Research and Commercial Applications in the Life Sciences |
View summary |
D03-2435 | Download this Insight |
Nanotechnology research aims to develop tools for studying and manipulating matter at the nanoscale—typically 0.1 nanometer to 100 nanometers—and to find ways to take advantage of properties or phenomena unique at the nanoscale to build materials and components. Combining this technology with biotechnology promises to open the door to an array of improved research tools and processes in the life sciences. At present, nanotechnologys greatest impact in the life sciences is in the development of improved research instrumentation and process capabilities. The future could also bring biology-based approaches to technology development and fabrication, such as molecular-scale tools for medical applications. Though industry participants agree that nanobiotechnology promises to launch a revolution in scientific and technological innovation, they disagree about the most realistic time frame for development and commercialization. The timing will depend on continued development of scientific research tools and methods, improved understanding of biological systems, support for interdisciplinary research, and development of an infrastructure for the testing, approval, and sale of nanobiotechnology-based products. Author: Andrew Broderick. 14 pages. Index Keywords: Biotechnology; Health Care; Information Technology; Medical Research; Nanotechnology; Pharmaceutical Industry. |
|
Benchmarking Corporate Performance: Emerging Tools and Metrics | View summary |
D03-2436 | Download this Insight |
Recent high-profile corporate-accounting scandals in the United States have engendered new skepticism about the accuracy, effectiveness, and observance of generally accepted accounting principals (GAAP), the standard for reporting company performance in the United States. These events—which include the bankruptcies of Enron Corp. (Houston, Texas), WorldCom Group (Clinton, Mississippi), Global Crossing Ltd. (Hamilton, Bermuda), and auditing firm Arthur Andersen LLP (Chicago, Illinois)—have spawned efforts to address a number of issues relating to corporate-governance structures, corporate-performance reporting, and accounting methods. As recent corporate scandals have increasingly highlighted the limitations of GAAP accounting, a number of other metrics, which focus on broader measures of corporate performance, are receiving increasing attention. As a result, a body of work is emerging that will allow firms to respond to regulations and investor demands for additional measures of corporate performance. As companies face increasing demand from investors and regulators to measure their performance beyond traditional financial standards, successful firms will undergo an active reevaluation process to implement new measures and standards to assess their performance. The use of new metrics, such as those that this study mentions, could result in higher levels of investor confidence and could ultimately result in a new source of competitive advantage. Author: Miguel de Figueiredo and Thomas M. McKenna. 10 pages. Index Keywords: Corporate Finance; Finance; Governance; Management; Strategic Management. |
|
Ten Lessons in Technology Development from Explorer | View summary |
D03-2437 | Download this Insight |
With more than 20 years experience monitoring emerging technologies, SRI Consulting Business Intelligences Explorer service has gained important insights useful for all companies wishing to understand the full commercialization potential of emerging technologies and in avoiding potential threats to market success. This study relates ten lessons from the Explorer services monitoring of emerging information, materials, communications, and biotechnologies in the past 20 years. Above all, Explorer analysts have learned that technologies follow natural evolutionary cycles that usually defy media hype and often survive the subsequent disappointments when market projections fail to materialize. Although planners seeking to understand the opportunities inherent in any emerging technology need to be aware of the hype phenomenon, they should not forsake investing enough to evaluate emerging technologies and monitor the underlying business or scientific activity to gauge the true development cycle. Authors: Andrew Broderick, Brock Hinzmann, and Thomas M. McKenna. 15 pages. Index Keywords: Research and Development; Strategic Planning; Technology Development; Technology Management. |